Ignet

Gene Information

Gene symbol: GAP43

Gene name: growth associated protein 43

HGNC ID: 4140

Synonyms: B-50, PP46

Related Genes

#	Gene Symbol	Number of hits
1	BAX	1 hits
2	BCL2	1 hits
3	NFATC1	1 hits
4	NPHS1	1 hits
5	RCAN1	1 hits

Related Sentences

#	PMID	Sentence
1	34746448	GAP-43 ameliorates Podocyte injury by decreasing nuclear NFATc1 expression.
2	34746448	We found that the decreased expression of nephrin, the cell marker of the podocyte, was significantly recovered with GAP-43 overexpression.
3	34746448	Moreover, overexpression of GAP-43 attenuated podocyte apoptosis by up-regulating the ratio of Bcl-2/Bax with LPS treatment.
4	34746448	Finally, Plaue and Rcan1 which are downstream target gene of NFATc1 decreased with overexpression of GAP-43 podocytes.
5	34746448	We concluded that GAP-43 attenuated podocyte injury by inhibiting calcineurin/NFATc1 signaling.
6	34746448	GAP-43 ameliorates Podocyte injury by decreasing nuclear NFATc1 expression.
7	34746448	We found that the decreased expression of nephrin, the cell marker of the podocyte, was significantly recovered with GAP-43 overexpression.
8	34746448	Moreover, overexpression of GAP-43 attenuated podocyte apoptosis by up-regulating the ratio of Bcl-2/Bax with LPS treatment.
9	34746448	Finally, Plaue and Rcan1 which are downstream target gene of NFATc1 decreased with overexpression of GAP-43 podocytes.
10	34746448	We concluded that GAP-43 attenuated podocyte injury by inhibiting calcineurin/NFATc1 signaling.
11	34746448	GAP-43 ameliorates Podocyte injury by decreasing nuclear NFATc1 expression.
12	34746448	We found that the decreased expression of nephrin, the cell marker of the podocyte, was significantly recovered with GAP-43 overexpression.
13	34746448	Moreover, overexpression of GAP-43 attenuated podocyte apoptosis by up-regulating the ratio of Bcl-2/Bax with LPS treatment.
14	34746448	Finally, Plaue and Rcan1 which are downstream target gene of NFATc1 decreased with overexpression of GAP-43 podocytes.
15	34746448	We concluded that GAP-43 attenuated podocyte injury by inhibiting calcineurin/NFATc1 signaling.
16	34746448	GAP-43 ameliorates Podocyte injury by decreasing nuclear NFATc1 expression.
17	34746448	We found that the decreased expression of nephrin, the cell marker of the podocyte, was significantly recovered with GAP-43 overexpression.
18	34746448	Moreover, overexpression of GAP-43 attenuated podocyte apoptosis by up-regulating the ratio of Bcl-2/Bax with LPS treatment.
19	34746448	Finally, Plaue and Rcan1 which are downstream target gene of NFATc1 decreased with overexpression of GAP-43 podocytes.
20	34746448	We concluded that GAP-43 attenuated podocyte injury by inhibiting calcineurin/NFATc1 signaling.
21	34746448	GAP-43 ameliorates Podocyte injury by decreasing nuclear NFATc1 expression.
22	34746448	We found that the decreased expression of nephrin, the cell marker of the podocyte, was significantly recovered with GAP-43 overexpression.
23	34746448	Moreover, overexpression of GAP-43 attenuated podocyte apoptosis by up-regulating the ratio of Bcl-2/Bax with LPS treatment.
24	34746448	Finally, Plaue and Rcan1 which are downstream target gene of NFATc1 decreased with overexpression of GAP-43 podocytes.
25	34746448	We concluded that GAP-43 attenuated podocyte injury by inhibiting calcineurin/NFATc1 signaling.